KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
AMS:PHIA - Euronext Amsterdam - NL0000009538 - Common Stock - Currency: EUR
PHIA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 55 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHIA have multiple concerns. PHIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
PHIA had positive earnings in the past year.
PHIA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
PHIA's Return On Assets of -1.43% is on the low side compared to the rest of the industry. PHIA is outperformed by 60.78% of its industry peers.
PHIA has a Return On Equity of -3.54%. This is in the lower half of the industry: PHIA underperforms 60.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROIC | N/A |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA's Operating Margin has declined in the last couple of years.
PHIA has a worse Gross Margin (41.56%) than 68.63% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for PHIA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% |
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
PHIA has less shares outstanding than it did 1 year ago.
PHIA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PHIA has a worse debt to assets ratio.
2.2 Solvency
PHIA has an Altman-Z score of 1.66. This is a bad value and indicates that PHIA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.66, PHIA is in line with its industry, outperforming 45.10% of the companies in the same industry.
The Debt to FCF ratio of PHIA is 7.27, which is on the high side as it means it would take PHIA, 7.27 years of fcf income to pay off all of its debts.
PHIA's Debt to FCF ratio of 7.27 is fine compared to the rest of the industry. PHIA outperforms 60.78% of its industry peers.
PHIA has a Debt/Equity ratio of 0.60. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
PHIA has a Debt to Equity ratio of 0.60. This is in the lower half of the industry: PHIA underperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Altman-Z | 1.66 |
ROIC/WACCN/A
WACC6.04%
2.3 Liquidity
PHIA has a Current Ratio of 1.16. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PHIA (1.16) is worse than 74.51% of its industry peers.
A Quick Ratio of 0.74 indicates that PHIA may have some problems paying its short term obligations.
With a Quick ratio value of 0.74, PHIA is not doing good in the industry: 68.63% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.65% over the past year.
Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.67% on average per year.
Looking at the last year, PHIA shows a decrease in Revenue. The Revenue has decreased by -2.65% in the last year.
Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 0.05% on average per year.
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
3.2 Future
PHIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.34% yearly.
The Revenue is expected to grow by 3.64% on average over the next years.
EPS Next Y14.33%
EPS Next 2Y11.67%
EPS Next 3Y12.92%
EPS Next 5Y15.34%
Revenue Next Year-1.9%
Revenue Next 2Y1.25%
Revenue Next 3Y2.36%
Revenue Next 5Y3.64%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.11, which indicates a rather expensive current valuation of PHIA.
Compared to the rest of the industry, the Price/Earnings ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 80.39% of the companies listed in the same industry.
PHIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.47.
With a Price/Forward Earnings ratio of 16.77, PHIA is valued correctly.
PHIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PHIA is cheaper than 70.59% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 92.74. PHIA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.11 | ||
| Fwd PE | 16.77 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHIA is on the same level as its industry peers.
PHIA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PHIA is cheaper than 86.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.44 | ||
| EV/EBITDA | 31.35 |
4.3 Compensation for Growth
PHIA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as PHIA's earnings are expected to grow with 12.92% in the coming years.
PEG (NY)1.4
PEG (5Y)N/A
EPS Next 2Y11.67%
EPS Next 3Y12.92%
5. Dividend
5.1 Amount
PHIA has a Yearly Dividend Yield of 4.15%, which is a nice return.
Compared to an average industry Dividend Yield of 2.44, PHIA pays a better dividend. On top of this PHIA pays more dividend than 98.04% of the companies listed in the same industry.
PHIA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
5.2 History
The dividend of PHIA decreases each year by -65.46%.
Dividend Growth(5Y)-65.46%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of PHIA are negative and hence is the payout ratio. PHIA will probably not be able to sustain this dividend level.
DP-0.48%
EPS Next 2Y11.67%
EPS Next 3Y12.92%
KONINKLIJKE PHILIPS NV
AMS:PHIA (2/4/2025, 7:00:00 PM)
25.94
-0.35 (-1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.12%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap24.38B
Analysts71.85
Price Target28.93 (11.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
Yearly Dividend0
Dividend Growth(5Y)-65.46%
DP-0.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.06%
Min EPS beat(2)-13.15%
Max EPS beat(2)-6.96%
EPS beat(4)1
Avg EPS beat(4)-8.37%
Min EPS beat(4)-25.88%
Max EPS beat(4)12.53%
EPS beat(8)3
Avg EPS beat(8)19.85%
EPS beat(12)3
Avg EPS beat(12)2.62%
EPS beat(16)7
Avg EPS beat(16)5.54%
Revenue beat(2)0
Avg Revenue beat(2)-2.71%
Min Revenue beat(2)-2.95%
Max Revenue beat(2)-2.46%
Revenue beat(4)0
Avg Revenue beat(4)-3.39%
Min Revenue beat(4)-7.41%
Max Revenue beat(4)-0.75%
Revenue beat(8)2
Avg Revenue beat(8)-0.89%
Revenue beat(12)2
Avg Revenue beat(12)-1.44%
Revenue beat(16)2
Avg Revenue beat(16)-3.44%
PT rev (1m)-0.1%
PT rev (3m)-3.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-5.05%
EPS NY rev (3m)-7.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)-2.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.11 | ||
| Fwd PE | 16.77 | ||
| P/S | 1.34 | ||
| P/FCF | 21.44 | ||
| P/OCF | 13.55 | ||
| P/B | 2.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 31.35 |
EPS(TTM)1.29
EY4.97%
EPS(NY)1.55
Fwd EY5.96%
FCF(TTM)1.21
FCFY4.66%
OCF(TTM)1.92
OCFY7.38%
SpS19.29
BVpS12.64
TBVpS-1.53
PEG (NY)1.4
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% | ||
| FCFM | 6.27% |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
F-Score5
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Debt/EBITDA | 7.18 | ||
| Cap/Depr | 51.64% | ||
| Cap/Sales | 3.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 181.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 1.66 |
F-Score5
WACC6.04%
ROIC/WACCN/A
Cap/Depr(3y)53.02%
Cap/Depr(5y)58.22%
Cap/Sales(3y)4.17%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
EPS Next Y14.33%
EPS Next 2Y11.67%
EPS Next 3Y12.92%
EPS Next 5Y15.34%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
Revenue Next Year-1.9%
Revenue Next 2Y1.25%
Revenue Next 3Y2.36%
Revenue Next 5Y3.64%
EBIT growth 1Y20.11%
EBIT growth 3Y-39.56%
EBIT growth 5Y-26.36%
EBIT Next Year69.31%
EBIT Next 3Y25.78%
EBIT Next 5YN/A
FCF growth 1Y-60.7%
FCF growth 3Y-2.55%
FCF growth 5Y0.39%
OCF growth 1Y-51.1%
OCF growth 3Y-5.06%
OCF growth 5Y-1.42%